Research Alliance Corp III
For the period ended Jun 30, 2026. Filed Aug 12, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 12, 2026
RACC$10.16+0.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| ExhibitNumber · Incorporation by Reference | |||||
|---|---|---|---|---|---|
| Description · Schedule/ Form · File Number · Exhibit · Filing Date | |||||
| 1.1 | Underwriting Agreement, dated May 19, 2026, between the Company and Leerink Partners LLC. | 8-K | 001-43302 | 1.1 | May 21, 2026 |
| 2.1 | Business Combination Agreement, dated as of July 26, 2026, by and among Research Alliance Corporation III, OHB Pediatrics Ltd. and the Shareholders named therein. | 8-K | 001-43302 | 2.1 | July 27, 2026 |
| 3.1 | Amended and Restated Memorandum and Articles of Association. | 8-K | 001-43302 | 3.1 | May 21, 2026 |
| 10.1 | Investment Management Trust Agreement, dated May 19, 2026, between Continental Stock Transfer & Trust Company and the Company. | 8-K | 001-43302 | 10.1 | May 21, 2026 |
| 10.2 | Registration and Shareholder Rights Agreement, dated May 19, 2026, by and among the Company, the Sponsor and the other parties thereto. | 8-K | 001-43302 | 10.2 | May 21, 2026 |
| 10.3 | Private Placement Shares Purchase Agreement, dated May 19, 2026, between the Company and the Sponsor. | 8-K | 001-43302 | 10.3 | May 21, 2026 |
| 10.4 | Form of Indemnity Agreement between the Company and each of the officers and directors of the Company. | 8-K | 001-43302 | 10.4 | May 21, 2026 |
| 10.5 | Indemnification Agreement, dated May 19, 2026, between the Company and the Sponsor. | 8-K | 001-43302 | 10.5 | May 21, 2026 |
| 10.6 | Letter Agreement, dated May 19, 2026, by and among the Company, the Sponsor, and each director and executive officer of the Company. | 8-K | 001-43302 | 10.6 | May 21, 2026 |
| 10.7 | Sponsor Letter Agreement, dated as of July 26, 2026, by and among Research Alliance Holdings III LLC, Research Alliance Corporation III, certain other holders of Research Alliance Corporation III Class B ordinary shares set forth on Schedule I thereto, and OHB Pediatrics Ltd. | 8-K | 001-43302 | 10.1 | July 27, 2026 |
| 10.8 | Form of OHB Pediatrics Ltd. SAFE | 8-K | 001-43302 | 10.2 | July 27, 2026 |
| 10.9 | Backstop Agreement, dated as of July 26, 2026, between Research Alliance Corporation III and RA Capital Healthcare Fund, L.P. | 8-K | 001-43302 | 10.3 | July 27, 2026 |
| 10.10 | Form of Subscription Agreement. | 8-K | 001-43302 | 10.4 | July 27, 2026 |
| 10.11 | Form of Investor Rights Agreement. | 8-K | 001-43302 | 10.5 | July 27, 2026 |
| 10.12 | Form of Lock-Up Agreement. | 8-K | 001-43302 | 10.6 | July 27, 2026 |
| 31.1* | Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | ||||
| 31.2* | Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
|---|---|
| 32.1** | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
| 32.2** | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
| 101.INS** | XBRL Instance Document |
| 101.SCH** | XBRL Taxonomy Extension Schema Document |
| 101.CAL** | XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF** | XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB** | XBRL Taxonomy Extension Labels Linkbase Document |
| 101.PRE** | XBRL Taxonomy Extension Presentation Linkbase Document |
| 104** | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
| * | Filed herewith. |
|---|
| ** | Furnished herewith and not deemed to be “filed” under the Securities Exchange Act of 1934, as amended. †Certain of the exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Registrant agrees to furnish a copy of all omitted exhibits and schedules to the SEC upon its request. |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.